Nonenzymatic post-translational modification derived products: New biomarkers of protein aging

Journal of Medical Biochemistry

Volumn 30, Issue 3, 2011, Pages 201-206

  Gillery, Philippe ^a  

^a AMERICAN MEMORIAL HOSPITAL   (France)

Author keywords

aging; carbamylation; chronic renal failure; diabetes mellitus; glycation; post translational modifications

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALDEHYDE; BIOLOGICAL MARKER; GLUCOSE; HOMOCITRULLINE; LYSINE; MEMBRANE RECEPTOR; MYELOPEROXIDASE; PROTEIN; THIOCYANATE; UREA;

AGING; ARTICLE; ATHEROSCLEROSIS; CARBAMOYLATION; CLINICAL PRACTICE; DIABETES MELLITUS; GLYCATION; HUMAN; IMMUNOASSAY; INFLAMMATION; KIDNEY FAILURE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OXIDATION; PROTEIN PROCESSING;

EID: 79959549337     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-011-0021-7     Document Type: Article

References (49)

1. Jaisson S, Gillery P. Evaluation of nonenzymatic posttranslational modification derived products as biomar k -ers of molecular aging of proteins. Clin Chem 2010; 56: 1401-12.
2. Baynes JW. The clinical chemome: a tool for the diag -nosis and management of chronic disease. Clin Chem 2004; 50: 1116-17. (Pubitemid 38824220)
3. Takeuchi M, Yamagishi S. Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular compli -cations and Alzheimer's disease. J Alzheimer Dis 2009; 16: 845-58.
4. Garnotel R, Sabbah N, Jaisson S, Gillery P. Enhanced activation of and increased production of matrix metalloproteinase-9 by human blood monocytes upon ad -hering to carbamylated collagen. FEBS Lett 2004; 563: 13-16. (Pubitemid 38471566)
5. Jaisson S, Lorimier S, Ricard-Blum S, Sockalingum GD, Delevallee-Forte C, Kegelaer G, et al. Impact of car -bamylation on type I collagen conformational structure and its ability to activate human polymorphonuclear neutrophils. Chem Biol 2006; 13: 149-59. (Pubitemid 43255587)
6. Shibayama R, Araki N, Nagai R, Horiuchi S. Auto -antibody against N(epsilon)-(carboxymethyl)lysine: an advanced glycation end product of the Maillard reaction. Diabetes 1999; 48: 1842-9. (Pubitemid 29415206)
7. Basta G. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications. Atherosclerosis 2008; 196: 9-21.
8. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001; 44: 129-46. (Pubitemid 32156196)
9. Gillery P, Monboisse JC, Maquart FX, Borel JP. Glycation of proteins as a source of superoxide. Diabete Metab 1988; 14: 25-30.
10. Olak E, Majkić-Singh N. The Effect of hyperglycemia and oxidative stress on the development and progress of vascular complications in type 2 diabetes. Journal of Medical Biochemistry 2009; 28:63-71
11. Witko-Sarsat V, Nguyen-Khoa T, Jungers P, Drueke TB, Descamps-Latscha B. Advanced oxidation protein prod ucts as a novel molecular basis of oxidative stress in uraemia. Nephrol Dial Transplant 1999; 14 Suppl 1: 76-8. (Pubitemid 29041848)
12. Ahmed N, Babaei-Jadidi R, Howell SK, Beisswenger PJ, Thornalley PJ. Degradation products of proteins da -maged by glycation, oxidation and nitration in clinical type 1 diabetes. Diabetologia 2005; 48: 1590-603. (Pubitemid 41175513)
13. Negre-Salvayre A, Coatrieux C, Ingueneau C, Salvayre R. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol 2008; 153: 6-20.
14. Kraus LM, Kraus AP, Jr. Carbamoylation of amino acids and proteins in uremia. Kidney Int Suppl 2001; 78: S102-7. (Pubitemid 32144080)
15. Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Horkko S, Barnard J, et al. Protein carbamylation links inflam -mation, smoking, uremia and atherogenesis. Nat Med 2007; 13: 1176-84. (Pubitemid 47530630)
16. Harding JJ. Viewing molecular mechanisms of ageing through a lens. Ageing Res Rev 2002; 1: 465-79. (Pubitemid 38340335)
17. Reddy VP, Zhu X, Perry G, Smith MA. Oxidative stress in diabetes and Alzheimer's disease. J Alzheimers Dis 2009; 16: 763-74.
18. Thornalley PJ. Advanced glycation end products in re -nal failure. J Ren Nutr 2006; 16: 178-84. (Pubitemid 43975005)
19. Ahmed N, Thornalley PJ. Advanced glycation end pro d -ucts: what is their relevance to diabetic complications? Diabetes Obes Metab 2007; 9: 233-45. (Pubitemid 46502041)
20. Sobal G, Sinzinger H, Menzel EJ. Binding of long-term glycated low density lipoprotein and AGE-albumin by peripheral monocytes and endothelial cells. J Recept Signal Transduct Res 1999; 19: 267-81. (Pubitemid 29152187)
21. Ferretti G, Bacchetti T, Negre-Salvayre A, Salvayre R, Dousset N, Curatola G. Structural modifications of HDL and functional consequences. Atherosclerosis 2006; 184: 1-7. (Pubitemid 41721062)
22. Holzer M, Gauster M, Pfeifer T, Wadsack C, Fauler G, Stiegler P, et al. Protein carbamylation renders highdensity lipoprotein dysfunctional [Epub ahead of print]. Antioxid Redox Signal 2011;as doi: 10.1089/ars. 2010.3640.
23. Carracedo J, Merino A, Briceno C, Soriano S, Buendia P, Calleros L, et al. Carbamylated low-density lipo protein induces oxidative stress and accelerated sene s -cence in human endothelial progenitor cells [Epub ahead of print]. FASEB J 2011;as doi: 10.1096/fj.10- 173377fj.
24. Little R, Rohlfing CL, Sacks DB. Status of haemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. Clin Chem 2011;57: 205-14.
25. Jeppsson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 2002; 40: 78-89. (Pubitemid 34196455)
26. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the Inter national Diabetes Federation. Diabetes Care 2007; 30: 2399-400.
27. Corbé-Guillard E, Jaisson S, Pileire C, Gillery P. Labile haemoglobin A1c: unexpected indicator of pre ana ly tical contraindications. Clin Chem 2011;57: 340-1.
28. Johnson RN, Metcalf PA, Baker JR. Fructosamine: a new approach to the estimation of serum glyco syl -protein. An index of diabetic control. Clin Chim Acta 1983; 127: 87-95. (Pubitemid 13168108)
29. Yoshiuchi K, Matsuhisa M, Kakatami N, Nakatami Y, Sakamoto K, Matsuoka T, et al. Glycated albumin is a better indicator for glucose excursion than glycated haemoglobin in type 1 and type 2 diabetes. Endocr J 2008; 55: 503-7. (Pubitemid 351949744)
30. Klaya F, Durlach V, Bertin E, Monier F, Monboisse JC, Gillery P. Evaluation of serum glycated lipoprotein(a) levels in noninsulin-dependent diabetic patients. Clin Biochem 1997; 30: 227-30. (Pubitemid 27225356)
31. Lutgers HL, Gerrits EG, Graaff R, Links TP, Sluiter WJ, Gans RO, et al. Skin autofluorescence provides ad ditional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia 2009; 52: 789-97.
32. Zhang X, Frischmann M, Kientsch-Engel R, Steinmann K, Stopper H, Niwa T, Pischetsrieder M. Two immuno -chemical assays to measure advanced glycation endproducts in serum from dialysis patients. Clin Chem Lab Med 2005; 43: 503-11. (Pubitemid 41460627)
33. Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, Dawnay A. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectro -metry. Biochem J 2003; 375: 581-92. (Pubitemid 37433506)
34. Seljeskog E, Hervig T, Mansoor MA. A novel HPLC method for the measurement of thiobarbituric acid reactive substances (TBARS). A comparison with a commercially available kit. Clin Biochem 2006; 39: 947-54. (Pubitemid 44344684)
35. Lapolla A, Flamini R, Dalla Vedova A, Senesi A, Reitano R, Fedele D, et al. Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method. Clin Chem Lab Med 2003; 41: 1166-73. (Pubitemid 37265695)
36. Selmeci L, Seres L, Antal M, Lukacs J, Regoly-Merei A, Acsady G. Advanced oxidation protein products (AOPP) for monitoring oxidative stress in critically ill patients: a simple, fast and inexpensive automated technique. Clin Chem Lab Med 2005; 43: 294-7.
37. Kato Y, Dozaki N, Nakamura T, Kitamoto N, Yoshida A, Naito M, et al. Quantification of Modified Tyrosines in Healthy and Diabetic Human Urine using Liquid Chromatography/Tandem Mass Spectrometry. J Clin Biochem Nutr 2009; 44: 67-78.
38. Kwan JT, Carr EC, Bending MR, Barron JL. Determi nation of carbamylated hemoglobin by high-performance liquid chromatography. Clin Chem 1990; 36: 607-10.
39. Hasuike Y, Nakanishi T, Maeda K, Tanaka T, Inoue T, Ta -kamitsu Y. Carbamylated hemoglobin as a thera pe utic marker in hemodialysis. Nephron 2002; 91: 228-34. (Pubitemid 34621688)
40. Szymezak J, Lavalard E, Martin M, Leroy N, Gillery P. Carbamylated hemoglobin remains a critical issue in HbA1c measurements. Clin Chem Lab Med 2009; 47: 612-13.
41. Thornalley PJ. Dietary AGEs and ALEs and risk to hu -man health by their interaction with the receptor for advanced glycation endproducts (RAGE) - an introduction. Mol Nutr Food Res 2007; 51: 1107-10.
42. Ahmed N, Babaei-Jadidi R, Howell SK, Thornalley PJ, Beisswenger PJ. Glycated and oxidized protein degra -dation products are indicators of fasting and post pran -dial hyperglycemia in diabetes. Diabetes Care 2005; 28: 2465-71. (Pubitemid 41384295)
43. Ahmed N, Thornalley PJ. Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydro xy -succinimidyl-carbamate and intrinsic fluorescence. Bio -chem J 2002; 364: 15-24. (Pubitemid 34538941)
44. Priego Capote F, Sanchez JC. Strategies for proteomic analysis of non-enzymatically glycated proteins. Mass Spectrom Rev 2009; 28: 135-46.
45. Petibois C, Cazorla G, Cassaigne A, Deleris G. Plasma pro tein contents determined by Fourier-transform in -frared spectrometry. Clin Chem 2001; 47: 730-8. (Pubitemid 32275818)
46. Glenn JV, Beattie JR, Barrett L, Frizzell N, Thorpe SR, Boulton ME, et al. Confocal Raman microscopy can quantify advanced glycation end product (AGE) mo -difications in Bruch's membrane leading to accu rate, nondestructive prediction of ocular aging. Faseb J 2007; 21: 3542-52. (Pubitemid 350075144)
47. Ceriello A, Ihnat MA, Thorpe JE. Clinical review 2: The metabolic memory: is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab 2009; 94: 410-15.
48. Delpierre G, Rider MH, Collard F, Stroobant V, Van -stapel F, Santos H, Van Schaftingen E. Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase. Diabetes 2000; 49: 1627-34.
49. Kalousova M, Zima T, Tesar V, Dusilova-Sulkova S, Skrha J. Advanced glycoxidation end products in chron -ic diseases-clinical chemistry and genetic background. Mutat Res 2005; 579: 37-46. (Pubitemid 41540131)